EschbachJW, EgrieJC, DowningMR, BrowneJK, Adam-son JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. NEJM1987;310:73–8.
2.
WinearlsCG, OliverDO, PipparelMJ, ReidC, DowningMR, CotesPM.Effect of human erythropoietin deprived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis. Lancet1986;11:1175–8.
3.
CasatiS, PasseriniP, CampiseMR, . Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis. Brit Med J1987;295:1017–20.
4.
WolcottDL, SchweitzerS, MarshJT, NissensonAR.Recombinant erythropoietin improves cognitive function and quality of life of chronic hemodialysis patients (Abstract). Amer Soc Nephrol1987.
5.
MoiaM, MannucciPM, VizzottoL, CasatiS, CattaneoM, PonticelliC.Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet1987;11:1227–9.
